Biogen Pharmachem Industries Ltd — Others, 25-08-2025: AGM/EGM

Biogen Pharmachem Industries will convene its 30th Annual General Meeting virtually. Shareholders will consider adopting the financial statements for FY25 and reappointing statutory auditors. Key special resolutions include appointing Mr. Kelash Bunkar as Whole-Time Director & CFO (on nil salary) for three years, and Mr. Aman Patel as an Independent Director for five years. The company also seeks to boost its borrowing power by Rs 100 Cr and enhance its investment, loan, and guarantee capacity by Rs 100 Cr, vital for funding future growth initiatives.